Trial Profile

Retrospective multicenter study to evaluate characteristics and treatment outcomes of patients treated with empagliflozin in association of british clinical diabetologists nationwide empagliflozin audit

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 Jul 2019 New trial record
11 Jun 2019 Results assessing predictors of glycaemic and weight response to empagliflozin treatment presented at the 79th Annual Scientific Sessions of the American Diabetes Association
11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com